All In Biotech

Drug Trial Radar · NCT06931405

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

A Phase 2 Study to Evaluate the Safety, Tolerability, and Clinical Activity of BLU-808, a Wild Type KIT Inhibitor, in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 110 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

110

Actual

Start

May 28, 2025

Primary completion

Oct 15, 2026

Study completion Oct 15, 2026

Sponsor

Sponsor type
Industry
First posted
Apr 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT inhibitor, in participants with CIndU (Part A) or CSU (Part B).

Conditions

  • Chronic Inducible Urticaria
  • Chronic Spontaneous Urticaria

Interventions

  • BLU-808Drug

    Oral administration

  • PlaceboDrug

    Oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A and Part B: Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 through Week 16

Locations

47 sites in 6 countries. Site status is shown where the registry gives one.

  • Allervie Clinical Research

    Birmingham, Alabama

  • Acuro Research, Inc.

    Little Rock, Arkansas

  • Modena Allergy & Asthma Clinical Research - La Jolla

    La Jolla, California

  • Allergy & Asthma Associates of Southern California

    Laguna Niguel, California

  • Allergy & Asthma Medical Group and Research Center

    San Diego, California

  • Allergy Affiliates Inc.

    Bradenton, Florida

  • University of South Florida

    Tampa, Florida

  • Treasure Valley Medical Research

    Boise, Idaho

  • Endeavor Health

    Northbrook, Illinois

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • Southern Indiana Clinical Trials

    New Albany, Indiana

  • The Indiana Clinical Trials Center

    Plainfield, Indiana

  • Equity Medical - Bowling Green

    Bowling Green, Kentucky

  • Johns Hopkins University

    Baltimore, Maryland

  • Institute For Asthma & Allergy

    Wheaton, Maryland

  • Chesapeake Clinical Research

    White Marsh, Maryland

  • Henry Ford Health

    Detroit, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • The Clinical Research Center LLC.

    St Louis, Missouri

  • Montana Medical Research, Inc.

    Missoula, Montana

  • Equity Medical (at Cameron Dermatology) - New York

    New York, New York

  • Bernstein Clinical Research Center

    Cincinnati, Ohio

  • Allergy & Clinical Immunology Associates

    Pittsburgh, Pennsylvania

  • National Allergy, Asthma & Urticaria Centers of Charleston

    Charleston, South Carolina

  • Medical University of South Carolina (MUSC)

    Charleston, South Carolina

  • Reveal Research Institute

    Dallas, Texas

  • Austin Institute for Clinical Research

    Pflugerville, Texas

  • Odense University Hospital - Odense

    Odense, Denmark

  • Fraunhofer-Institut fuer Translationale Medizin und Pharmakologie ITMP - Standort Berlin

    Berlin, Germany

  • Universitaetsklinikum Carl Gustav Carus Dresden

    Dresden, Germany

  • Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet

    Frankfurt am Main, Germany

  • Medizinische Hochschule Hannover (MHH)

    Hanover, Germany

  • Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz

    Mainz, Germany

  • Universitaetsklinikum Tuebingen

    Tübingen, Germany

  • Azienda Ospedale - Università Padova

    Padova, Italy

  • Azienda Ospedaliero Universitaria Policlinico Umberto

    Rome, Italy

  • Centro Ricerche Cliniche di Verona s.r.l.

    Verona, Italy

  • Hospital del Mar

    Barcelona, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, Spain

  • Hospital Universitari de Bellvitge

    Barcelona, Spain

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.